Literature DB >> 3193366

Linear and nonlinear system approaches in pharmacokinetics: how much do they have to offer? I. General considerations.

P Veng-Pedersen1.   

Abstract

System approaches in pharmacokinetics are defined as generalizing and simplifying modeling approaches that mathematically model a general property of the pharmacokinetic system without modeling specifically the individual kinetic processes responsible for the general property considered. The rationale for the use of system approaches is discussed and the kinetic basis of some of the approaches is presented. An overview of the approaches is presented together with a comparison to classical approaches involving specific pharmacokinetic models. Examples are given from different application areas involving problems in linear and nonlinear pharmacokinetics and in pharmacodynamics. The advantages, disadvantages, and limitations of the system approaches are discussed. In several application areas the system approach offers some rational methods and procedures with distinct advantages over more traditional approaches.

Mesh:

Year:  1988        PMID: 3193366     DOI: 10.1007/bf01062554

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  59 in total

1.  Theorems on linear systems.

Authors:  J Z HEARON
Journal:  Ann N Y Acad Sci       Date:  1963-05-10       Impact factor: 5.691

2.  Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.

Authors:  P V Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1977-10

3.  A note on appropriate constraints on the initial input response when applying deconvolution.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1986-08

4.  Theorems and implications of a model-independent elimination/distribution function decomposition of linear and some nonlinear drug dispositions. IV. Exact relationship between the terminal log-linear slope parameter beta and drug clearance.

Authors:  P Veng-Pedersen; W R Gillespie
Journal:  J Pharmacokinet Biopharm       Date:  1987-06

5.  A linear recirculation model for drug disposition.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1979-02

6.  A polyexponential deconvolution method. Evaluation of the "gastrointestinal bioavailability" and mean in vivo dissolution time of some ibuprofen dosage forms.

Authors:  W R Gillespie; P Veng-Pedersen
Journal:  J Pharmacokinet Biopharm       Date:  1985-06

7.  Numerical deconvolution by least squares: use of prescribed input functions.

Authors:  D J Cutler
Journal:  J Pharmacokinet Biopharm       Date:  1978-06

8.  Residence time and accumulation of drugs in the body.

Authors:  M Weiss
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1981-02

9.  Simultaneous pharmacokinetic and pharmacodynamic modeling.

Authors:  W A Colburn
Journal:  J Pharmacokinet Biopharm       Date:  1981-06

10.  A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery.

Authors:  W R Gillespie; P Veng-Pedersen; E J Antal; J P Phillips
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

View more
  23 in total

1.  Neural networks in pharmacodynamic modeling. Is current modeling practice of complex kinetic systems at a dead end?

Authors:  P Veng-Pedersen; N B Modi
Journal:  J Pharmacokinet Biopharm       Date:  1992-08

2.  The relevance of residence time theory to pharmacokinetics.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  Noncompartmental versus compartmental modelling in clinical pharmacokinetics.

Authors:  W R Gillespie
Journal:  Clin Pharmacokinet       Date:  1991-04       Impact factor: 6.447

Review 4.  Mean time parameters in pharmacokinetics. Definition, computation and clinical implications (Part II).

Authors:  P Veng-Pedersen
Journal:  Clin Pharmacokinet       Date:  1989-12       Impact factor: 6.447

5.  Evaluation of hepatic function using the pharmacokinetics of a therapeutically administered drug. Application to the immunosuppressant cyclosporin.

Authors:  W Weber; M Looby; J Brockmöller
Journal:  Clin Pharmacokinet       Date:  1992-07       Impact factor: 6.447

6.  Clearance of ceftriaxone in critical care patients with acute renal failure.

Authors:  G Heinemeyer; J Link; W Weber; V Meschede; I Roots
Journal:  Intensive Care Med       Date:  1990       Impact factor: 17.440

7.  Optimal extravascular dosing intervals.

Authors:  P Veng-Pedersen; N B Modi
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

8.  Stepwise determination of multicompartment disposition and absorption parameters from extravascular concentration-time data. Application to mesoridazine, flurbiprofen, flunarizine, labetalol, and diazepam.

Authors:  J G Wagner; D A Ganes; K K Midha; I Gonzalez-Younes; J C Sackellares; L D Olson; M B Affrime; J E Patrick
Journal:  J Pharmacokinet Biopharm       Date:  1991-08

9.  Nonlinear kinetics of the thiamine cation in humans: saturation of nonrenal clearance and tubular reabsorption.

Authors:  W Weber; M Nitz; M Looby
Journal:  J Pharmacokinet Biopharm       Date:  1990-12

10.  Pharmacokinetic differentiation of drug candidates using system analysis and physiological-based modelling. Comparison of C.E.R.A. and erythropoietin.

Authors:  Peter Veng-Pedersen; Kevin J Freise; Robert L Schmidt; John A Widness
Journal:  J Pharm Pharmacol       Date:  2008-10       Impact factor: 3.765

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.